Enhancement of gene therapy specificity for diffuse colon carcinoma liver métastases with recombinant herpes simplex virus

Annals of Surgery

Volumn 224, Issue 3, 1996, Pages 323-330

  Carroll, Nancy M ^a,b   Antonio Chiocca, E ^a   Takahashi, Kazuhisa ^a   Tanabe, Kenneth K ^a  

^a Division of Surgical Oncology   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; RIBONUCLEOTIDE REDUCTASE;

COLON CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; DNA SYNTHESIS; EXPRESSION VECTOR; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LIVER CELL; LIVER METASTASIS; PRIORITY JOURNAL; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; CARCINOMA; COLONIC NEOPLASMS; GENE THERAPY; GENETIC VECTORS; HUMANS; INJECTIONS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; RIBONUCLEOTIDE REDUCTASES; SIMPLEXVIRUS; SPLEEN; TUMOR CELLS, CULTURED;

EID: 0029680820     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199609000-00008     Document Type: Article

References (24)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer JCIin 1996:46:5-29.
2. Blumgart LH, Fong Y. Surgical options in the treatment of hepatic métastases from colorectal cancer. Curr Probl Surg 1995; 32:333421.
3. Clark JW. Targeted therapy. In: Chabner BA, Longo DL, ed. Cancer Chemotherapy and Biotherapy. Philadelphia, PA: Lippin cott-Raven Publishers, 1996; 691 -708.
4. Lever AML, Goodfellow P, eds. Gene therapy. Br Med Bull 1995; 51.
5. Boviatsis EJ, Chase M, Wei MX, et al. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum Gene Ther 1994; 5:183-191.
6. ChenS, Chen XHL, Wang Y, et al. Combination gene therapy for liver metastasis of colon carcinoma in viro. Proc Natl Acad Sei U SA 1995:92:2577-2581.
7. Caruso M, Panis Y, Gagandeep S, et al. Regression of established macroscopic liver métastases after in silu transduction of a suicide gene. Proc Natl Acad Sei U S A 1993; 90:7024-7028.
8. Hurford RK, Dranoff G, Mulligan RC, Tepper RI. Gene therapy of metastatic cancer by in v/Vo retroviral gene targing. Nature Gen 1995; 10:430-435.
9. Johnson PA, Yoshida K, Gage FH, Friedmann T. Cytotoxicity of a replication-defective mutant of herpes simplex virus type l.J Virol 1992:66:2952-2965.
10. Johnson PA, Yoshida K, Gage FH, Friedmann T. Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector. Mol Brain Res 1992; 12:95102.
11. Roizman B, ed. The Herpesviruses. Vol 3. New York: Plenum Press; 1985.
12. Boviatsis E), Park JS, Sena-Esteves M, et al. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus that retains an intact thymidine kinase gene. Cancer Res 1994:54:5745-5751.
13. Huffman AL, Rosen HR, Ljubimova JU, et al. Hepatic regeneration: current concepts and clinical implications. Semin Liver Dis 1994:14:190-210.
14. Mann GJ, Musgrove EA, Fox RM, Thelander L. Ribonucleotide reductase Ml subunit in cellular proliferation, quiescence, and differentiation. Cancer Res 1988; 48:5151-5156.
15. Goldstein DJ, Weller SK.. Factor(s) present in herpes simplex virus type 1 infected cells can compensate for the loss of the large unit of the viral ribonuclcotide reductase: characterization of an ICP6 deletion mutant. Virology 1988; 166:41-51.
16. Goldstein DJ, Weller SK. Herpes simplex virus type 1-inducedribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant. J Virol 1988;62:196-205.
17. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986; 89: 271-277.
18. Morikawa K, Walker SM, Jessup JM, et al. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res 1988:48:1943-1948.
19. Boviatsis EJ, Scharf JM, Chase M, et al. Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotidc reductase. Gene Ther 1994; 1:323-331.
20. Mineta T, Rabkin SD, Martuza RL. Treatment of malignant gliomas usingganciclovir-hypersensitivc, ribonucleotide reductase-de-ficient herpes simplex viral mutant. Cancer Res 1994; 54:39633966.
21. WoIfT JA, ed. Gene Therapeutics: Methods and Applications of Direct Gene Transfer. Boston, MA: Birkhauser; 1994.
22. Okamura-Oho Y, Zhang S, Callahan JW. The biochemistry and clinical features of galactosialidosis. Biochim Biophys Acta 1994; 1225:244-254.
23. Pitts JD. Cancer gene therapy: a bystander effect using the gap junctional pathway. Mol Carcinogen 1994; 11:127-130.
24. Freeman SM, Abboud CN, Whartenby KA, et al. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53:5274-5283.